A clinical practice viewpoint: to culture or not to culture Helicobacter pylori? (Q35170767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

A clinical practice viewpoint: to culture or not to culture Helicobacter pylori? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

C Hassan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Lorenzetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Winn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Morini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

357-361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

Ueber die schlauchförmigen Drüsen des Magendarmkanals und die Beziehungen ihres Epithels zu dem Oberflächenepithel der Schleimhaut Dritte Mittheilung

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

The Campylobacter pylori story.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., Respectively

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

The complete genome sequence of the gastric pathogen Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Helicobacter pylori: diseases, tests and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

"Cervia Working Group Report": guidelines on the diagnosis and treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Rescue Therapy for Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

A triple therapy regimen after failed Helicobacter pylori treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Treatment after failure: the problem of "non-responders".

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Molecular testing for antibiotic resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Bacteriology of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Two-day 'weekend' lansoprazole-quadruple therapy for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Antibiotic resistance of Helicobacter pylori strains in Japanese children

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi Teaching Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Pretreatment antimicrobial-susceptibility testing in the eradication of H. pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

In vitro selection of resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Proton pump inhibitors--differences emerge in hepatic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Helicobacter pylori eradication: do we have another ace up our sleeve?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900081-1

7 January 2021

10.1016/S1590-8658(03)00081-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846409%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference